Financial reports
Current reports
6-K
Current report (foreign)
8 Apr 24
6-K
Casi Pharmaceuticals Announces Fourth Quarter and Full-year 2023 Business and Financial Results
28 Mar 24
6-K
Current report (foreign)
13 Mar 24
6-K
Current report (foreign)
29 Feb 24
6-K
Current report (foreign)
9 Feb 24
6-K
Current report (foreign)
30 Jan 24
6-K
Current report (foreign)
15 Dec 23
6-K
Current report (foreign)
8 Dec 23
6-K
Casi Pharmaceuticals Announces Third Quarter 2023 Business and Financial Updates
14 Nov 23
6-K
Casi Pharmaceuticals Announces Market Approval of CNCT19 by China Nmpa
8 Nov 23
Registration and prospectus
F-3
Shelf registration (foreign)
3 May 24
S-8 POS
Registration of securities for employees (post-effective amendment)
22 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
22 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
22 May 23
S-8 POS
Registration of securities for employees (post-effective amendment)
22 May 23
8-A12B
Registration of securities on exchange
27 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Mar 23
Proxies
No filings